

Visualize how your peptide clears from the body — half-life, steady state, and accumulation for every injection schedule.
Half-Life
~4 h
Time for 50 % to be eliminated
Steady State
~17 h
≈ 4.3 half-lives
Accumulation
×1.02
Cmax at steady state ÷ Cmax first dose
Gone After
~1.2 days
after last dose
Source: FDA FORZINITY Integrated Review, 2025, Table 103: healthy subjects after intravenous infusion, six participants per cohort, cohort mean half-lives 3.23 to 3.93 hours. About four hours is a rounded IV study reference, supported by the FDA-reviewed original data rather than the Szeto review. It is not a universal SS-31 formulation or route value.. Research tool. Uses a simplified first-order elimination model and normalizes concentration to % of peak. Not a medical or dosing recommendation. SS-31: ~4 h.
Visualize how your peptide clears from the body — half-life, steady state, and accumulation for every injection schedule.
Half-Life
~4 h
Time for 50 % to be eliminated
Steady State
~17 h
≈ 4.3 half-lives
Accumulation
×1.02
Cmax at steady state ÷ Cmax first dose
Gone After
~1.2 days
after last dose
Source: FDA FORZINITY Integrated Review, 2025, Table 103: healthy subjects after intravenous infusion, six participants per cohort, cohort mean half-lives 3.23 to 3.93 hours. About four hours is a rounded IV study reference, supported by the FDA-reviewed original data rather than the Szeto review. It is not a universal SS-31 formulation or route value.. Research tool. Uses a simplified first-order elimination model and normalizes concentration to % of peak. Not a medical or dosing recommendation. SS-31: ~4 h.